Comparison of Two Novel Indirect Laryngoscopes to the Macintosh Laryngoscope in Patients With Cervical Spine Immobilization.
NCT ID: NCT01032460
Last Updated: 2010-11-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2010-01-31
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The Airtraq® Laryngoscope and the CMAC are new intubating devices. They are designed to provide a view of the glottis without alignment of the oral, pharyngeal and tracheal axes.
These devices may be especially effective in situations where intubation of the trachea is potentially difficult.
The efficacy of these devices in comparison to the traditional Macintosh laryngoscope in situations where the cervical spine is immobilized is not known.
The investigators aim to compare the performances of the Airtraq® Laryngoscope and the CMAC to that of the Macintosh laryngoscope, the gold standard device, in patients in which the cervical spine has been immobilized by means of a Manual in-line stabilization of the spine.
Hypothesis: The primary hypothesis is that, in the hands of experienced anaesthetists, time to intubation would be shorter using the indirect laryngoscopes, than using the Macintosh laryngoscope in simulated difficult laryngoscopy.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
macintosh
intubate with the macintosh laryngoscope
intubate with the macintosh laryngoscope
C-MAC
intubate with the C-MAC laryngoscope
intubate with the C-MAC laryngoscope
Airtraq
intubate with the Airtraq device
intubate with the Airtraq device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intubate with the macintosh laryngoscope
intubate with the macintosh laryngoscope
intubate with the C-MAC laryngoscope
intubate with the C-MAC laryngoscope
intubate with the Airtraq device
intubate with the Airtraq device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18 - 85 years
* Written informed Consent
* No relevant drug allergies
* Mallampatti 1 - 2.
Exclusion Criteria
* Patients with predicted difficult intubation
* Mallampatti III or IV
* Thyromental distance \< 6cm
* Mouth opening \< 3.5 cm
* Cervical spine disease
* Anteriorly protruding incisors
* Poor Dentition (2)
* Tumours, polyps or foreign bodies in the upper airway (2)
* Patients with documented difficult airways (2).
* Patients with history of or risk factors for gastric regurgitation (i.e. require rapid sequence induction of anaesthesia)
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College Hospital Galway
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
National University of Ireland, Galway
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Galway University Hospital
Galway, Galway, Ireland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMAC-3
Identifier Type: -
Identifier Source: org_study_id